CoChat

The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.

Comparative Proteomics Reveals a Significant Bias Toward Alternative Protein Isoforms with Conserved Structure and Function

Open access
Ezkurdia, I., del Pozo, A., Frankish, A., Rodriguez, J. M., Harrow, J., Ashman, K., Valencia, A., Tress, M. L. · 2012 · Molecular Biology and Evolution

Abstract

Advances in high-throughput mass spectrometry are making proteomics an increasingly important tool in genome annotation projects. Peptides detected in mass spectrometry experiments can be used to validate gene models and verify the translation of putative coding sequences (CDSs). Here, we have identified peptides that cover 35% of the genes annotated by the GENCODE consortium for the human genome as part of a comprehensive analysis of experimental spectra from two large publicly available mass spectrometry databases. We detected the translation to protein of "novel" and "putative" protein-coding transcripts as well as transcripts annotated as pseudogenes and nonsense-mediated decay targets. We provide a detailed overview of the population of alternatively spliced protein isoforms that are detectable by peptide identification methods. We found that 150 genes expressed multiple alternative protein isoforms. This constitutes the largest set of reliably confirmed alternatively spliced proteins yet discovered. Three groups of genes were highly overrepresented. We detected alternative isoforms for 10 of the 25 possible heterogeneous nuclear ribonucleoproteins, proteins with a key role in the splicing process. Alternative isoforms generated from interchangeable homologous exons and from short indels were also significantly enriched, both in human experiments and in parallel analyses of mouse and Drosophila proteomics experiments. Our results show that a surprisingly high proportion (almost 25%) of the detected alternative isoforms are only subtly different from their constitutive counterparts. Many of the alternative splicing events that give rise to these alternative isoforms are conserved in mouse. It was striking that very few of these conserved splicing events broke Pfam functional domains or would damage globular protein structures. This evidence of a strong bias toward subtle differences in CDS and likely conserved cellular function and structure is remarkable and strongly suggests that the translation of alternative transcripts may be subject to selective constraints.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/molbev/mss100

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Annotation of putative and novel isoforms. In A, the GENCODE annotation for the COL6A3 locus viewed using the Ensembl genome browser. The large arrow picks out the “novel” transcript ENST00000472056 annotated for this gene. The transcript is missing three nonconsecutive exons (small arrows) at the 3′ end, and we detected 40 PSM that mapped uniquely to this isoform. In B, the GENCODE annotation for the APOA1 locus viewed using the Ensembl genome browser. The large arrow picks out the “putative” transcript ENST00000375329 annotated for this gene. The transcript codes for a different N-terminal, and we detected 56 PSM for this isoform.
FIG. 1. Annotation of putative and novel isoforms. In A, the GENCODE annotation for the COL6A3 locus viewed using the Ensembl genome browser. The large arrow picks out the “novel” transcript ENST00000472056 annotated for this gene. The transcript is missing three nonconsecutive exons (small arrows) at the 3′ end, and we detected 40 PSM that mapped uniquely to this isoform. In B, the GENCODE annotation for the APOA1 locus viewed using the Ensembl genome browser. The large arrow picks out the “putative” transcript ENST00000375329 annotated for this gene. The transcript codes for a different N-terminal, and we detected 56 PSM for this isoform.CC BY-NC · PubMed Central
FIG. 2. NMD target RBM6-005. The GENCODE annotation for the RBM6 locus viewed using the Ensembl genome browser showing the peptide detected for NMD-targeted isoform RBM6-005 (ENST00000425068). GENCODE currently annotates 22 variants for this gene, not all are shown for clarity. Transcript RBM6-005 skips the exon marked with the arrow that leads to a frame shift and a premature stop codon. Transcript RBM6-005 is highlighted below and aligned with the detected peptide fragment (in the shaded box). The dash (–) in the peptide sequence marks where the peptide spans the exon junction.
FIG. 2. NMD target RBM6-005. The GENCODE annotation for the RBM6 locus viewed using the Ensembl genome browser showing the peptide detected for NMD-targeted isoform RBM6-005 (ENST00000425068). GENCODE currently annotates 22 variants for this gene, not all are shown for clarity. Transcript RBM6-005 skips the exon marked with the arrow that leads to a frame shift and a premature stop codon. Transcript RBM6-005 is highlighted below and aligned with the detected peptide fragment (in the shaded box). The dash (–) in the peptide sequence marks where the peptide spans the exon junction.CC BY-NC · PubMed Central
FIG. 3. PSMD4 splice isoforms. (A) The four annotated isoforms of PSMD4 aligned. Shaded areas represent the peptides found in the experiments. The strength of shading denotes the total number of unique peptide-spectra matches encountered for each peptide. Just two of the isoforms were detected in the proteomics studies—they differed by a three-residue indel. (B) The detected peptides are shown mapped onto the Protein Data Bank (PDB) (Berman et al. 2000) structure 2X5N, which is 50% identical to the N-terminal of PSMD4, and onto 1YX4, the structure of the central section of the PSMD4 isoforms. Most of the structure of 1YX4 is disordered (the image is just one of the 15 NMR models of 1YX4), and the three extra residues detected for isoform ENST00000368881 would be inserted in a disordered region, as indicated by the arrow.
FIG. 3. PSMD4 splice isoforms. (A) The four annotated isoforms of PSMD4 aligned. Shaded areas represent the peptides found in the experiments. The strength of shading denotes the total number of unique peptide-spectra matches encountered for each peptide. Just two of the isoforms were detected in the proteomics studies—they differed by a three-residue indel. (B) The detected peptides are shown mapped onto the Protein Data Bank (PDB) (Berman et al. 2000) structure 2X5N, which is 50% identical to the N-terminal of PSMD4, and onto 1YX4, the structure of the central section of the PSMD4 isoforms. Most of the structure of 1YX4 is disordered (the image is just one of the 15 NMR models of 1YX4), and the three extra residues detected for isoform ENST00000368881 would be inserted in a disordered region, as indicated by the arrow.CC BY-NC · PubMed Central
FIG. 4. The active site of the two isoforms detected for ketohexokinase (KHK). The structures of the two KHK isoforms detected in the experiments are known. The structure of the fructose-binding site of the “peripheral” isoform (3NBV) is shown superimposed on the fructose-binding site of the “central” isoform (2HQQ). The closest residues to the fructose substrate for each isoform are shown in stick form. The binding residues are identical and are oriented in an almost identical form, with the exception of those residues in the region coded for by the homologous exon. These are the two beta sheets on the right of the image. Here, the residues in contact with the fructose are different in the two isoforms, alanine and tyrosine in the central isoform and leucine and isoleucine in the peripheral. Despite the differences, the substituted residues have similar hydrophobicity, and both isoforms were crystallized with bound fructose (not shown) and have conserved catalytic residues (López et al. 2007).
FIG. 4. The active site of the two isoforms detected for ketohexokinase (KHK). The structures of the two KHK isoforms detected in the experiments are known. The structure of the fructose-binding site of the “peripheral” isoform (3NBV) is shown superimposed on the fructose-binding site of the “central” isoform (2HQQ). The closest residues to the fructose substrate for each isoform are shown in stick form. The binding residues are identical and are oriented in an almost identical form, with the exception of those residues in the region coded for by the homologous exon. These are the two beta sheets on the right of the image. Here, the residues in contact with the fructose are different in the two isoforms, alanine and tyrosine in the central isoform and leucine and isoleucine in the peripheral. Despite the differences, the substituted residues have similar hydrophobicity, and both isoforms were crystallized with bound fructose (not shown) and have conserved catalytic residues (López et al. 2007).CC BY-NC · PubMed Central
FIG. 5. Functional bias and the genes with alternative isoforms. The genes from the AI Detected set were clustered into four groups based on their functional annotations. In part B, the percentage of genes in three functional clusters and the remaining genes (Miscellaneous). Mean values for the features from table 1 were calculated for the genes from each of the groups. These values were normalized by the scores from the AI Detected set and are plotted in A. The cytoskeleton subset has a much higher number of exons and longer sequence, and their alternative isoforms have a much higher probability of detection in proteomics experiments. Peptides for the “immune response” genes are detected in much higher numbers in the proteomics experiments (the number of PSM). We detected substantially fewer PSM for the RNA-binding subset than for the rest of the AI Detected set.
FIG. 5. Functional bias and the genes with alternative isoforms. The genes from the AI Detected set were clustered into four groups based on their functional annotations. In part B, the percentage of genes in three functional clusters and the remaining genes (Miscellaneous). Mean values for the features from table 1 were calculated for the genes from each of the groups. These values were normalized by the scores from the AI Detected set and are plotted in A. The cytoskeleton subset has a much higher number of exons and longer sequence, and their alternative isoforms have a much higher probability of detection in proteomics experiments. Peptides for the “immune response” genes are detected in much higher numbers in the proteomics experiments (the number of PSM). We detected substantially fewer PSM for the RNA-binding subset than for the rest of the AI Detected set.CC BY-NC · PubMed Central
FIG. 6. Alternative isoforms generated from three subsets are supported by more peptide evidence. The percentage of PSM that distinguish alternative isoforms (the AP Score) contrasted with the theoretical likelihood of detecting splice isoforms (detectability) calculated for each of the eight subsets from the AI Detected set. Detectability is calculated from the number of PSM detected for the each gene and the theoretical probability of detection, both normalized by the equivalent values from the Background set. The higher the detectability, the more likely we are to detect PSM that match to alternative isoforms. The AP Score is surprisingly high for three of the groups (the hnRNP genes, the genes with isoforms generated from NAGNAG splicing, and the genes with alternative isoforms generated from homologous exons).
FIG. 6. Alternative isoforms generated from three subsets are supported by more peptide evidence. The percentage of PSM that distinguish alternative isoforms (the AP Score) contrasted with the theoretical likelihood of detecting splice isoforms (detectability) calculated for each of the eight subsets from the AI Detected set. Detectability is calculated from the number of PSM detected for the each gene and the theoretical probability of detection, both normalized by the equivalent values from the Background set. The higher the detectability, the more likely we are to detect PSM that match to alternative isoforms. The AP Score is surprisingly high for three of the groups (the hnRNP genes, the genes with isoforms generated from NAGNAG splicing, and the genes with alternative isoforms generated from homologous exons).CC BY-NC · PubMed Central
FIG. 7. Alternative splice isoforms detected for human, mouse, and Drosophila. The proportion of genes with detected alternative isoforms that come from hnRNP genes, that have alternative isoforms generated from homologous exons, and that have alternative isoforms generated by NAGNAG splicing (or small indels), in different proteomics experiments for Drosophila, human, and mouse.
FIG. 7. Alternative splice isoforms detected for human, mouse, and Drosophila. The proportion of genes with detected alternative isoforms that come from hnRNP genes, that have alternative isoforms generated from homologous exons, and that have alternative isoforms generated by NAGNAG splicing (or small indels), in different proteomics experiments for Drosophila, human, and mouse.CC BY-NC · PubMed Central
FIG. 8. Pfam functional domain damage in isoforms generated from different sets of genes. The y axis shows the percentage of isoforms with Pfam domains defined as damaged. The x axis shows the five sets of isoforms tested. The isoforms detected in proteomics experiments for the genes in the Background set, the isoforms not detected in proteomics experiments for the genes in the Background set, the main isoform detected for each gene in the AI Detected set (the isoform that most PSM mapped to), the alternative isoforms detected for each gene in the AI Detected set, and the isoforms not detected for each gene in the AI Detected set.
FIG. 8. Pfam functional domain damage in isoforms generated from different sets of genes. The y axis shows the percentage of isoforms with Pfam domains defined as damaged. The x axis shows the five sets of isoforms tested. The isoforms detected in proteomics experiments for the genes in the Background set, the isoforms not detected in proteomics experiments for the genes in the Background set, the main isoform detected for each gene in the AI Detected set (the isoform that most PSM mapped to), the alternative isoforms detected for each gene in the AI Detected set, and the isoforms not detected for each gene in the AI Detected set.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 95 references

Research works printed but not linked: 5

  1. 2009, Genome Research, 20, 45
  2. 2009, Nucleic Acids Research, 38, D211
  3. 1997, 197, 73
  4. 2010, BMC bioinformatics [electronic resource], 11, S14
  5. 2006, 380, 63

Cited by

See all 95

Metadata

Authors
Ezkurdia, I., del Pozo, A., Frankish, A., Rodriguez, J. M., Harrow, J., Ashman, K., Valencia, A., & Tress, M. L.
Affiliations
  • Spanish National Cancer Research Centre (ES)
  • Wellcome Sanger Institute (GB)
Corresponding author
  • Valencia, A.
  • Tress, M. L.
Venue
Molecular Biology and Evolution
Published
2012-03-22
Volume
29
Issue
9
Pages
2265-2283
ISSN
  • 0737-4038 (ISSN-L)
  • 1537-1719
OpenAlex
W2156052197
Cited by
89
References
95
Citations by year
2026: 1 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 7 · 2017: 9 · 2016: 2 · 2015: 13 · 2014: 8 · 2013: 13 · 2012: 15
FWCI
6.92
Type
journal article
Language
en
Open access
Locations
  • Molecular Biology and Evolution (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Ministerio de Ciencia e Innovación (BIO2007-66855, CSD2007-00050)
  • National Institutes of Health (5u54hg004555-04)
  • Instituto de Salud Carlos III
  • National Human Genome Research Institute (U54-HG004555, U54 HG0004555)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
Keywords
alternative splicing, human genome annotation, GENCODE, peptide identification, pseudogenes, nonsense-mediated mRNA decay, heterogeneous nuclear ribonucleoproteins, indels, protein structure conservation
MeSH terms
Amino Acid Sequence, Animals, Drosophila, Humans, Models, Molecular, Molecular Sequence Data, Peptides, Protein Conformation, Proteins, Protein Biosynthesis, Sequence Alignment, Genome, Alternative Splicing, Protein Isoforms, Catalytic Domain, Proteomics, Proteasome Endopeptidase Complex, Mice, Protein Interaction Domains and Motifs, Molecular Sequence Annotation, Nonsense Mediated mRNA Decay

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative Proteomics Reveals a Significant Bias Toward Alternative Protein Isoforms with Conserved Structure and Function. https://app.cochat.ai/papers/10.1093/molbev/mss100
The paper
Ezkurdia, I., del Pozo, A., Frankish, A., Rodriguez, J. M., Harrow, J., Ashman, K., Valencia, A., & Tress, M. L. (2012). Comparative Proteomics Reveals a Significant Bias Toward Alternative Protein Isoforms with Conserved Structure and Function. Molecular Biology and Evolution. https://doi.org/10.1093/molbev/mss100

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.